Search News Releases
You can use the filters to refine your search.
Displaying 1 - 20 of 3935
While use of insulin pumps to manage type 1 diabetes has grown over 20 years, there has been no improvement in racial, ethnic, and socioeconomic disparities in their use.
UCLA Health has been recognized as a recipient of the WebMD Choice Awards for excellence in five specialties: Oncology, Cardiology, Orthopaedics, Neurology and Gastroenterology. This is the only hospital-recognition program based solely on the preferences and perceptions of patients and physicians on a local level.
Dr. Sara Hurvitz of UCLA Health and the Jonsson Comprehensive Cancer Center presented study results from three trials at the San Antonio Breast Cancer Symposium.
Long COVID patients can experience many of the same lingering negative effects on their physical, mental, and social well-being as those experienced by people who become ill with other, non-COVID illnesses
UCLA Health has selected a team of experts to transform a former medical center into a state-of-the-art neuropsychiatric hospital that will help address the region’s unmet need for behavioral health services.
The authors say genetic correlation estimates deserve more scrutiny, since these estimates have been used to predict disease risk, inform diagnostic practices and therapy development, and shape arguments about human behavior.
Research finds low-certainty evidence that programs such as emergency rent assistance, legal assistance with waitlist priority for public housing, long-term rent subsidies and homeownership assistance lead to positive health outcomes.
Sex differences in the aging brain may offer an enticing clue for developing more effective neuroprotective treatments, according to a new treatment development strategy from UCLA researchers.
The UCLA Center for SMART Health, an interdisciplinary collaborative that looks to the integrated transformation of healthcare through emergent data and technologies, and Hearst Health, a division of Hearst and leader in care guidance, yesterday announced that Constant Therapy Health is the winner of the 2022 Hearst Health Prize.
The study refines scientists' understanding of how autism progresses at the molecular level and could better inform the development of new treatments.
New onset chronic kidney disease (CKD) in people with diabetes is highest among racial and ethnic minority groups compared with white persons
A five-year, $8 million grant from the California Institute for Regenerative Medicine will enable UCLA stem cell scientists to include a wider cross-section of Los Angeles’ diverse population in potentially lifesaving medical research.
New research will aim to identify electrical activity occurring as the brain receives information and then test whether targeted, gentle electrical stimulation can strengthen memory.
Roni Haas, PhD, postdoctoral scholar in the lab of Paul Boutros has received the 2022 Todd Boehly-PCF Young Investigator Award from the Prostate Cancer Foundation. The award will support Haas’s prostate cancer research project, Associating Germline Variants with Prostate Tumor Evolution and Lethality, at total of $225,000 over three years.
Telehealth follow-up consultations following an emergency department visit were associated with 28 more repeat ED encounters and nearly 11 more return hospital admissions per 1000 patients compared with in-person follow-ups.
In the future, this model can be used by researchers to discover targets for treatments that improve walking, cognitive, coordination and visual disabilities in MS.
Preclinical studies in mice that model human COVID-19 suggest that an inexpensive, readily available amino acid might limit the effects of the disease and provide a new off-the-shelf therapeutic option for infections with SARS-CoV-2 variants and perhaps future novel coronaviruses.
In a large analysis of over 7,000 men treated internationally across 12 randomized trials, Jonsson Comprehensive Cancer Center researchers have shown that it is almost universally optimal for men to begin androgen deprivation therapy when starting radiation, so that most of the period of having a low testosterone is "backloaded" after radiation is complete.